Order results by:
| Issue | Title | |
| Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
| I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
| "... Objective: to study various typological characteristics of the retail pharmaceutical market sector ..." | ||
| Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
| "... at the expense of personal funds of citizens in the retail sector of the pharmaceutical market of the Russian ..." | ||
| Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
| "... for the treatment of diabetes mellitus (DM), sold in the retail sector of the pharmaceutical market of the Russian ..." | ||
| Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract similar documents |
| I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
| "... drugs, their fixed combinations (FC), as well as statins in the retail sector of the pharmaceutical ..." | ||
| Vol 16, No 2 (2023) | Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice | Abstract similar documents |
| M. S. Soboleva | ||
| "... to pharmacy organizations during provision of pharmaceutical assistance. Material and methods. A prospective ..." | ||
| Vol 5, No 1 (2012) | PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING | Abstract similar documents |
| M. V. Protsenko, N. I. Koroleva | ||
| "... results as a new instrument in pharmaceutical marketing lets marketing specialists know what information ..." | ||
| Vol 18, No 1 (2025) | Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... toxicity tests) and are used in pharmaceutical, cosmetic and food industries as stabilizers/preservatives ..." | ||
| Vol 5, No 2 (2012) | WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM | Abstract similar documents |
| A. I. Borodin | ||
| "... Research of experience of the firm which is engaged in pharmaceutical business, has confirmed ..." | ||
| Vol 18, No 1 (2025) | Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia | Abstract similar documents |
| A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova | ||
| "... ) is altering the structure of the pharmaceutical market by amplifying the share of domestic manufacturers ..." | ||
| Vol 14, No 2 (2021) | Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care | Abstract similar documents |
| D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh | ||
| "... Objective: to analyze the availability and affordability of pharmaceuticals for children in need ..." | ||
| Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract similar documents |
| I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
| Vol 14, No 1 (2021) | Differences in the standardization of medicinal products based on extracts of chondroitin sulfate | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina | ||
| "... . It was shown that the assessments of the pharmaceutical quality of the studied extracts made by the elemental ..." | ||
| Vol 17, No 1 (2024) | Compounding pharmacy regulations: experience of the Latvian pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| "... pharmaceutical market to improve approaches for statutory regulation of this special and socially significant ..." | ||
| Vol 14, No 2 (2021) | Survey-based evaluation of the awareness of pharmaceutical specialists on the pharmacotherapy of climacteric syndrome | Abstract similar documents |
| M. A. Chernyavskaya, I. A. Narkevich | ||
| "... Objective: to evaluate the awareness of pharmaceutical specialists on the pharmacotherapy ..." | ||
| Vol 13, No 2 (2020) | Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome | Abstract similar documents |
| M. A. Chernyavskaya, I. A. Narkevich | ||
| Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| "... of the compounding pharmacy regulation in North American pharmaceutical market. The main imperatives are identified ..." | ||
| Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
| E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
| "... and the dynamics of the return on shares of the pharmaceutical sector for Russia and the United States. Material ..." | ||
| Vol 17, No 2 (2024) | Mathematical modeling and analysis of export trends for certain pharmaceutical groups | Abstract similar documents |
| А. R. Shaikhislamova, N. А. Gasratova | ||
| "... (pharmaceutical products) of the commodity nomenclature of foreign economic activity of the Eurasian Economic ..." | ||
| Vol 5, No 1 (2012) | UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES | Abstract similar documents |
| A. Y. Kulikov, A. G. Voskanyan | ||
| "... The article covers the key issues of local pharmaceutical production and ensuring of equitable ..." | ||
| Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract similar documents |
| F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
| "... names (INN) of anticancer drugs, whose generics or biosimilars entered the Russian pharmaceutical market ..." | ||
| Vol 17, No 4 (2024) | Scenario modeling of the drug prescription process for children: application of machine learning methods | Abstract similar documents |
| А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova | ||
| "... systems of the pharmaceutical care structure. Material and methods. The study was based on data on drug ..." | ||
| Vol 7, No 2 (2014) | THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID | Abstract similar documents |
| K. V. Danilova, I. M. Razdorskaya | ||
| "... in the present paper we have studied a group of pharmaceutical drugs used in the treatment ..." | ||
| Vol 15, No 2 (2022) | The current state of the veterinary drugs market in the Tyumen Region | Abstract similar documents |
| V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina | ||
| "... of the assortment of veterinary pharmaceutical organizations and clinics (retail segment of the market) revealed low ..." | ||
| Vol 17, No 4 (2024) | Regional aspects of availability of expectorants and antitussive drugs | Abstract similar documents |
| V. М. Timiryanova, А. V. Samorodov, Z. А. Valiullina, V. B. Prudnikov, D. Kh. Krasnoselskaya | ||
| "... and methods. The study was carried out using data from the online retail sales analytics service in the RF ..." | ||
| Vol 15, No 1 (2022) | Application of chondroprotective agents to inhibit osteodestructive processes in the subchondral bone in patients with osteoarthritis | Abstract PDF (Eng) similar documents |
| О. А. Gromova, А. М. Lila, I. Yu. Torshin, I. А. Reier | ||
| "... (клетки, деградирующие костную ткань). Заключение. Фармацевтически стандатизированные формы ХС и ГС могут ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
| A. V. Rudakova, Т. V. Korotaeva | ||
| "... on the pharmaceutical market of the Russian Federation. Material and methods. The evaluation of clinical and economic ..." | ||
| Vol 6, No 3 (2013) | THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT | Abstract similar documents |
| N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova | ||
| "... The range and sales analysis of pharmaceuticals for the dysmenorrhea treatment on the market ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system | Abstract similar documents |
| A. V. Rudakova, I. Z. Gaydukova | ||
| "... . A time horizon of the study was set at 2 years. Costs of pharmaceuticals were calculated according ..." | ||
| Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract similar documents |
| M. B. Kubaeva, Y. Sh. Guchshina | ||
| "... -sponsored prices and the retail prices of these medications has an impact on the costs of ant-HIV therapy. ..." | ||
| Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
| V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... . The government agencies determine the list of reimbursable pharmaceuticals and medical services and also define ..." | ||
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| Vol 14, No 1 (2021) | Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 | Abstract similar documents |
| O. V. Zhukova, A. L. Khokhlov | ||
| "... of clinical and economic constituents of the application of an IL-6 inhibitor tocilizumab and systemic ..." | ||
| Vol 16, No 3 (2023) | Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation | Abstract similar documents |
| D. V. Fedyaev, F. S. Nikitin, T. N. Artamonova, S. A. Kovaleva, V. V. Omelyanovskiy | ||
| "... Background. Each constituent entity of the Russian Federation (RF) on the basis of the territorial ..." | ||
| Vol 17, No 1 (2024) | Assessing the awareness of doctors of various specialties in the treatment of osteoporosis | Abstract similar documents |
| V. A. Alekseeva, A. V. Krikova, Т. Yu. Filatova, E. V. Dmitrieva, A. V. Ovsyankin, E. S. Kuzminova | ||
| "... фармацевтических работников, поэтому следует рассмотреть их более тесное взаимодействие по вопросам профилактики и ..." | ||
| Vol 9, No 3 (2016) | MONITORING OF CONSUMER ATTITUDES TO MEDICINES | Abstract similar documents |
| N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
| "... . Six of these qualities characterize the pharmaceutical features and merchandising options are seven ..." | ||
| Vol 15, No 3 (2022) | Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study | Abstract similar documents |
| V. V. Strizheletsky, Yu. М. Gomon, Е. А. Spichakova, А. S. Kolbin, А. А. Kalyapin, S. А. Makarov, А. B. Lomiya, F. М. Sultanova | ||
| "... . Material and methods. From IQVIA database, the information was selected on retail sales and procurement ..." | ||
| Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
| "... and GS pharmaceutical substances with a high degree of purification from inorganic and organic impurities ..." | ||
| Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
| D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
| Vol 16, No 1 (2023) | Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program | Abstract similar documents |
| T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina | ||
| Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
| D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
| "... of drugs for the treatment of rare (orphan) diseases. Material and methods. Analysis of pharmaceutical ..." | ||
| Vol 14, No 1 (2021) | Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District | Abstract similar documents |
| M. S. Soboleva, E. E. Loskutova | ||
| "... -group analysis of retail of antihypertensive drugs for 2019 in drugstores of the Khabarovsk Region ..." | ||
| Vol 14, No 2 (2021) | Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev | ||
| "... the pharmaceuticals registered in the Anatomical, Therapeutic, and Chemical Classifier (ATC). Material and methods ..." | ||
| Vol 12, No 2 (2019) | Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU | Abstract similar documents |
| G. N. Gildeeva, A. V. Belostotsky | ||
| "... countries in order to adopt the strategy of the pharmaceutical industry players. Materials and methods ..." | ||
| Vol 9, No 1 (2016) | REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES | Abstract similar documents |
| K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... to expenditure growth have focused on outpatient pharmaceuticals, evaluation of medical technologies and reducing ..." | ||
| Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
| "... characteristics of ω -3 PUFAs pharmaceutical forms and the modern statistical analysis of biomedical data ..." | ||
| Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
| A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
| "... to the level identified in a previous retrospective analysis of the pharmaceutical market. The baseline ..." | ||
| Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
| "... Introduction. The pharmaceutical drugs used in the treatment of osteoarthritis (OA) differ ..." | ||
| Vol 15, No 1 (2022) | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom | Abstract similar documents |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| "... are exempt from payments to stimulate innovative development of the pharmaceutical industry and accelerate ..." | ||
| Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
| "... on pharmaceutical standardized forms of CS and GS in terms of lung function. ..." | ||
| Vol 18, No 1 (2025) | Systematic analysis of molecules regulating nitric oxide (NO) metabolism and vascular endothelium condition | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| "... of glycosaminoglycans with a high degree of pharmaceutical standardization) is one of the promising areas of therapy ..." | ||
| 1 - 50 of 72 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
